Recruiting Sepsis Studies in Orange
Stress Hydrocortisone In Pediatric Septic Shock
SHIPSS is a multi-institutional, prospective, controlled, randomized, double-blinded interventional trial that will examine the potential benefits and risks of adjunctive hydrocortisone prescribed for...
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in chil...
About Sepsis Clinical Trials in Orange
Sepsis is a life-threatening condition that arises when the body's response to an infection damages its own tissues and organs. It can rapidly progress to septic shock and multi-organ failure. Treatment requires urgent antibiotics, IV fluids, and intensive care support.
There are currently 2 sepsis clinical trials recruiting participants in Orange, CALIFORNIA. These studies are seeking a combined 1,000 participants. Research is being sponsored by Jerry Zimmerman, Nationwide Children's Hospital. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sepsis Clinical Trials in Orange — FAQ
Are there sepsis clinical trials in Orange?
Yes, there are 2 sepsis clinical trials currently recruiting in Orange, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Orange?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orange research site will contact you about next steps.
Are clinical trials in Orange free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orange studies also compensate for your time and travel.
What sepsis treatments are being tested?
The 2 active trials in Orange are testing new therapies including novel drugs, biologics, and treatment approaches for sepsis.
Data updated March 2, 2026 from ClinicalTrials.gov